Neuphoria Therapeutics's total assets for Q1 2026 were $27.34M, a decrease of -99.90% from the previous quarter. NEUP total liabilities were $14.83M for the fiscal quarter, a -99.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.